This summary covers recent health news, including stable pig prices in Germany, investor focus on AstraZeneca's China probe, ...

In a report released today, Emily Field from Barclays maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of ...

Prime Minister Keir Starmer said it was a “commercial decision” by a major international biopharmaceutical firm to pull out ...

Quantum computing is shaping up to be the next big investing revolution, and for a very good reason. With the power to solve ...

Amgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...

Google's balance sheet is impressive, with negative long-term debt, $110 billion in cash, and a forward dividend yield of ...

TD Cowen analyst Steve Scala maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $32.00. The company’s ...

FTSE Climbs on rate cut hopes amid inflation heat; GSK Soars 7.6%. US trade gap widens.

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...